The European Cancer Conference (ECCO), the leading multidisciplinary oncology platform in Europe, took place in Paris from October 30 to November 3, 2005. One of the highlights was a discussion of a ...

Managing the side effects in patients being treated for metastatic breast cancer can be challenging. Recently, Marla D. Lipsyc-Sharf, MD, a breast medical oncologist and health sciences clinical ...

CePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Metabolic dysfunction-associated steatohepatitis (MASH) is one of ...

As conversations around longevity and ‘bio-hacking’ gain momentum, a drug once reserved for highly specific medical use is ...